We are live on ! Find out more
JR

John Rogers Ariel Investments

AUM $10B
1-Year Est. Return 42.59%
 

John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+42.59%
3 Year Est. Return
+78.13%
5 Year Est. Return
+79.56%
10 Year Est. Return
+301.99%
AUM
$8.86B
AUM Growth
+$249M
Cap. Flow
-$166M
Cap. Flow %
-1.88%
Top 10 Hldgs %
25.28%
Holding
180
New
4
Increased
77
Reduced
87
Closed
8

Sector Composition

Rank Sector Weight
1 Financials 22.6%
2 Industrials 14.03%
3 Communication Services 13.94%
4 Technology 12.42%
5 Healthcare 12.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
176
InterDigital
IDCC
$8.84B
-35,122
Closed -$2.59M
IWR icon
177
iShares Russell Mid-Cap ETF
IWR
$57.7B
-14,596
Closed -$719K
VOO icon
178
Vanguard S&P 500 ETF
VOO
$1.02T
-21,290
Closed -$4.91M
ESIO
179
DELISTED
Electro Scientific Industries
ESIO
-207,062
Closed -$2.88M
PCO
180
DELISTED
Pendrell Corporation - Class A
PCO
-10,436
Closed -$7.13M

Similar funds

John Rogers's Q4 2017 Portfolio in Review

As of Q4 2017, John Rogers held 180 positions worth $8.86B, up 2.9% from $8.61B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

John Rogers's Q4 2017 filing shows 4 new, 77 increased, 87 reduced and 8 closed positions. Its largest new stake was Methode Electronics: 363,583 shares worth $14.6M. The largest sale was Bio-Rad Laboratories Class A, an estimated $62.2M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Communication Services.

  • John Rogers's largest Q4 2017 buy was Methode Electronics: 363,583 shares worth $14.6M.
  • John Rogers added most to SLB Ltd in Q4 2017, an estimated $47.5M increase.
  • John Rogers's biggest Q4 2017 reduction was Bio-Rad Laboratories Class A, cutting an estimated $62.2M.
  • John Rogers fully exited Franklin Templeton, Inc. in Q4 2017, selling an estimated $13.2M.
  • John Rogers's ten largest holdings make up 25% of its $8.86B portfolio in Q4 2017.
  • John Rogers opened 4 new positions and closed 8 in Q4 2017.
  • John Rogers's portfolio value rose 2.9% quarter-over-quarter to $8.86B.

Based on Ariel Investments's 13F filing for Q4 2017, filed 14 Feb 2018.